Research programme: peptide therapeutics - Sapience Therapeutics
Alternative Names: peptide therapeutics - Sapience TherapeuticsLatest Information Update: 02 Jun 2021
At a glance
- Originator Sapience Therapeutics
- Class Antivirals; Peptides
- Mechanism of Action Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research COVID 2019 infections